Cytotoxic T lymphocytes
Showing 1 - 25 of >10,000
Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)
Recruiting
- Multiple Myeloma
- TAA-specific CTLs
- TAA-specific CTLs- fixed dose
-
Houston, TexasHouston Methodist Hospital
Nov 11, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)
Active, not recruiting
- Acute Lymphocytic Leukemia
- Lymphoma
- Biological/Genetically Modified T cells
- Cyclophosphamide-based chemotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)
Recruiting
- Hodgkins Lymphoma
- Non Hodgkins Lymphoma
- TAA-specific CTLs
-
Houston, TexasTexas Children's Hospital
Jul 14, 2022
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Adenovirus
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +8 more
Sep 27, 2022
Covid19 Trial in Philadelphia (Cytotoxic T Lymphocytes)
Active, not recruiting
- Covid19
- Cytotoxic T Lymphocytes
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 15, 2022
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +3 more
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
-
Columbus, Ohio
- +1 more
Apr 20, 2022
Breast Cancer Trial in Houston (TAA-specific CTLs)
Active, not recruiting
- Breast Cancer
- TAA-specific CTLs
-
Houston, Texas
- +1 more
May 20, 2022
Congenital Cytomegaloviral (CMV) Disease Trial in United States (CMV Cytotoxic T-Lymphocytes, Anti-viral Therapy)
Recruiting
- Congenital Cytomegaloviral (CMV) Disease
- CMV Cytotoxic T-Lymphocytes
- Anti-viral Therapy
-
Saint Louis, Missouri
- +3 more
Oct 24, 2022
Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)
Recruiting
- Cytomegalovirus Infections
- Primary Immune Deficiency Disorder
- viral specific cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Rhabdomyosarcoma Trial in Houston (TAA-Specific CTLs)
Completed
- Rhabdomyosarcoma
- TAA-Specific CTLs
-
Houston, Texas
- +1 more
Apr 8, 2022
Pancreatic Cancer Trial in Houston (multiTAA specific T cells)
Active, not recruiting
- Pancreatic Cancer
- multiTAA specific T cells
-
Houston, Texas
- +2 more
Feb 7, 2022
Viral Infections After HSCT Trial in Washington (VSTs)
Active, not recruiting
- Viral Infections After HSCT
- VSTs
-
Washington, District of ColumbiaChildrens National Medical Center
Aug 30, 2022
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)
Active, not recruiting
- Lymphoma
- +3 more
- TGFbeta resistant LMP-specific CTLs
-
Houston, Texas
- +1 more
Dec 8, 2021
Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)
Terminated
- Serologically Active Adult Systemic Lupus Erythematosus
- Autologous EBV specific CTL infusion
-
Nantes, France
- +2 more
Mar 24, 2022
Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)
Recruiting
- Adenovirus Infection
- +6 more
- Virus-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2023
AIDS, BK Virus Infection, Human Immunodeficiency Virus Trial in Houston (Allogeneic BK-specific Cytotoxic T-lymphocytes,
Recruiting
- Acquired Immunodeficiency Syndrome
- +7 more
- Allogeneic BK-specific Cytotoxic T-lymphocytes
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 29, 2021
Epstein-Barr Virus Infections, Adenovirus, Cytomegalovirus Infections Trial in Milwaukee (Cytotoxic T Lymphocytes)
Completed
- Epstein-Barr Virus Infections
- +2 more
- Cytotoxic T Lymphocytes
-
Milwaukee, WisconsinMedical College of Wisconsin
Oct 21, 2021
Transplant Failure Trial in Marseille (BLOOD SAMPLE ANALYSIS)
Recruiting
- Transplant Failure
- BLOOD SAMPLE ANALYSIS
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Oct 28, 2021
Covid19 Trial in United States (Standard of Care, SARS-CoV2-CTLS)
Recruiting
- Covid19
- Standard of Care
- SARS-CoV2-CTLS
-
Valhalla, New York
- +3 more
Jan 10, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022